Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity

Metformin is the first-line drug in the treatment of type 2 diabetes. In addition to its hypoglycemic effect, metformin has an anti-inflammatory function, but the precise mechanism promoting this activity remains unclear. High mobility group box 1 (HMGB1) is an alarmin that is released from necrotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Horiuchi, Takahiro, Sakata, Natsumi, Narumi, Yoshihiro, Kimura, Tomohiro, Hayashi, Takashi, Nagano, Keisuke, Liu, Keyue, Nishibori, Masahiro, Tsukita, Sohei, Yamada, Tetsuya, Katagiri, Hideki, Shirakawa, Ryutaro, Horiuchi, Hisanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2017
Materias:
Molecular Bases of Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437248/
https://www.ncbi.nlm.nih.gov/pubmed/28373282
http://dx.doi.org/10.1074/jbc.M116.769380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437248/
https://www.ncbi.nlm.nih.gov/pubmed/28373282
http://dx.doi.org/10.1074/jbc.M116.769380

Ejemplares similares